Webinar Recording Available: Writing the “Indications and Usage” Section of Labeling: FDA’s New Draft Guidance
To anyone who had difficulty joining the September 27th webinar, please pardon our technical limitations as the number participants exceeded capacity. The recording is available in video or audio.
Webinar Recording Available: Writing the “Indications and Usage” Section of Labeling: FDA’s New Draft Guidance This webinar provides insight on FDA’s recommendations for the “Indications and Usage” section of labeling as outlined in the draft guidance Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products – Content and Format.
To anyone who had difficulty joining the September 27th webinar, please pardon our technical limitations as the number participants exceeded capacity. The recording is available in video or audio.
Webinar Recording Available: Writing the “Indications and Usage” Section of Labeling: FDA’s New Draft Guidance This webinar provides insight on FDA’s recommendations for the “Indications and Usage” section of labeling as outlined in the draft guidance Indications and Usage Section of Labeling for Human Prescription Drug and Biological Products – Content and Format.
More InformationVisit CDER SBIA Learn for more on-demand webinars, recorded workshops, and resources such as:
- CDER SBIA Prescription Drug Labeling Conference (Session recordings available)
- The Ins and Outs of Presenting Clinical Pharmacology Information in Prescription Drug Labeling (Webinar recording available)
- FDA Regulatory Education for Industry Training - Spring 2018 (Session recordings available)
.png)
No hay comentarios:
Publicar un comentario